The present invention provides AA targeting compounds which comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. Various uses of the compounds are provided, including methods to treat disorders connected to abnormal angiogenesis.
本发明提供了
AA靶向化合物,其中包括与
抗体结合位点连接的
AA靶向剂-连接剂共轭物。提供了化合物的各种用途,包括治疗与异常血管生成有关的疾病的方法。